knowledge -WSS

knowledge

author：hotspot 2025-09-27 23:02:55 - browse：88277

An advisory committee to the Food and Drug Administration will convene on Tuesday to evaluate the benefits of renal denervation, a one-time surgical procedure that works to reduce blood pressure. The promise — and the potential market — is enormous, but the data on how well the procedure works remains contentious.

The committee will evaluate data from two companies vying for market approval: ReCor Medical, a startup owned by Japanese company Otsuka Medical Devices, and device giant Medtronic, both of which have made surgical systems to treat hypertension.

Data from an analysis of three randomized clinical trials of ReCor Medical’s device showed a modest decrease in blood pressure after two months compared to a control group that received a placebo procedure. Medtronic’s late-stage trial showed that renal denervation reduced hypertension when measuring blood pressure in the doctor’s office, but did not show a reduction in blood pressure when patients measured it at home over 24 hours. At-home blood pressure is considered the more accurate measure, as blood pressure levels tend to artificially rise with anxiety in the clinic. Neither study presented serious safety concerns.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Wildfire smoke exposes gaps in outdoor worker protections
Next article： NEJM study link tiny plastics in blood vessels to heart problems

WSS

Brazil's Jair Bolsonaro is barred from running for office until 2030

The sun may be out, but guns are not. A lawsuit challenges a new gun ban on Hawaii beaches

IVF, abortion rights issues kick off Biden’s State of the Union

IVF, abortion rights issues kick off Biden’s State of the Union

IVF, abortion rights issues kick off Biden’s State of the Union

Readout LOUD podcast: Venture capital turmoil, obesity drug competition

hotspot

knowledge

hotspot

ChatGPT in medicine: STAT answers readers' burning questions

ADA: All diabetes patients should be screened for liver condition

FDA approval of Sarepta Duchenne genetic therapy gives me hope

The strange history of BMI, the body mass index

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

NEJM study link tiny plastics in blood vessels to heart problems

BioMarin wins approval for gene therapy to treat hemophilia A

Sen. Paul opposes bill to ban Chinese biotechs

Walensky prepares to leave CDC — and Congress — behind

Prince Harry seeks over $550,000 in phone hacking lawsuit against British tabloid publisher

entertainment

Why do we get seasonal allergies?

Readout Newsletter: Acadia, Eli Lilly, Madrigal Pharma updates

Novo Nordisk obesity pill bests Wegovy in early trial

Readout LOUD podcast: Venture capital turmoil, obesity drug competition

In surprise move, FDA calls for advisory committee on Lilly's Alzheimer's drug

Federal board approves $12.7 billion budget for Puerto Rico as island shakes off bankruptcy

explore

explore

entertainment

focus